The seminal microbiome is the community of microorganisms (bacteria, viruses, fungi, and archaea) present in semen.
Just like other microbiomes in the body, the balance of this community is essential for the proper functioning of the male reproductive system and has a direct impact on the fertility of couples seeking to conceive.
Seminal infections, caused by pathogenic or opportunistic microorganisms, are associated with up to 15% of male infertility cases.
An imbalance in the seminal microbiome can:
Cause inflammation or obstruction of the genital tract.
Impair sperm quality, reducing viability and motility.
Increase DNA fragmentation and oxidative stress.
Crucially, the seminal microbiota can be transmitted to the partner during intercourse. This may alter the vaginal microbiome and potentially interfere with embryo implantation.
Test Emi focuses on a detailed evaluation of the presence of a wide variety of microorganisms in semen (including bacteria, viruses, and fungi).
Test Emi utilizes quantitative real-time PCR (RT-qPCR) molecular testing, making it highly specific for detecting these microorganisms.
Detection of ‘Hidden Microbes’: This technique is so sensitive that it can identify microorganisms that are difficult or impossible to culture in a traditional laboratory, even at very low levels.
Rapid results: PCR detection is much faster than culture tests, which can take several days.
Comprehensive analysis: Enables the identification and typing of key species, such as Lactobacillus, to determine which species dominate the seminal ecosystem.
Sperm production issues
Reproductive microbiota
Hormonal imbalances and/or physical issues
Test Emi performs a detailed evaluation of the presence of a wide variety of microorganisms in semen, including bacteria, archaea, viruses, and fungi.
This analysis allows for the identification of microbial imbalances or infections that may be compromising male fertility.
An altered seminal microbiome not only affects the male but can also influence the partner’s reproductive health.
During sexual intercourse, part of this microbiota can be transferred to the female partner, altering her vaginal microbiome and potentially hindering embryo implantation.
Characterizing the seminal microbiome can help identify therapeutic pathways to correct abnormalities in seminal parameters and improve fertility.
Couples with infertility attributed to male factor.
Men with abnormal semen analysis results (seminogram), especially those with severe sperm morphology issues.
Couples experiencing recurrent pregnancy loss of unknown origin and/or repeated implantation failure following assisted reproduction treatments.
Men who have been exposed (or suspect exposure) to Sexually Transmitted Infections (STIs).
Couples with dysbiosis or recurrent infections such as urinary tract infections (UTIs), bacterial vaginosis/vaginitis, candidiasis (yeast infections), etc.
To perform Test Emi, a semen sample is required.
To ensure the highest quality results, it is recommended that patients abstain from sexual intercourse and any type of ejaculation for 2 to 5 days prior to sample collection.
Once collected, the sample must be immediately placed in the container provided by your healthcare professional.
Test Emi is a key tool for identifying hidden causes of male infertility and guiding more effective treatments.
Additionally, it helps anticipate potential conception issues and improve success rates in reproductive treatments.
